Clinical Trial Update: Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating statin as neoadjuvant therapy for postmenopausal breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Statin (statin)

Snippet

Sponsor: Lund University Hospital | Conditions: Breast Cancer, Postmenopausal | Phase 2 | Status: COMPLETED